Tandem Diabetes Care Inc. (TNDM)

61.99
5.37 9.48
NASDAQ : Health Technology
Prev Close 56.62
Open 60.07
Day Low/High 59.66 / 62.30
52 Wk Low/High 26.40 / 74.81
Volume 2.86M
Avg Volume 1.31M
Exchange NASDAQ
Shares Outstanding 58.65M
Market Cap 3.32B
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Abbott And Tandem Diabetes Care Exploring New Integrated Solutions To Improve Diabetes Management

Abbott And Tandem Diabetes Care Exploring New Integrated Solutions To Improve Diabetes Management

- Companies aim to integrate Abbott's FreeStyle Libre glucose sensing technology with Tandem's insulin delivery products to expand choices for people with diabetes

Tandem Diabetes Care To Announce Third Quarter 2019 Financial Results On November 4, 2019

Tandem Diabetes Care To Announce Third Quarter 2019 Financial Results On November 4, 2019

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2019 results after the financial markets close on Monday, November 4, 2019.

7 Medical Products Stocks With the Right Prescription for Gains

7 Medical Products Stocks With the Right Prescription for Gains

Top picks in the fast-growing medical products market.

Tandem Diabetes Care Announces Publication Of Real-world Basal-IQ Predictive Low Glucose Suspend Technology Data In Diabetes Technology And Therapeutics Journal

Tandem Diabetes Care Announces Publication Of Real-world Basal-IQ Predictive Low Glucose Suspend Technology Data In Diabetes Technology And Therapeutics Journal

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced publication of real-world data from more than 8,000 users of the t:slim X2™ insulin pump with Basal-IQ® predictive low-glucose suspend...

Heavy Rotation

Monday was a 'Realization Day' when not a soul missed the move from growth to value.

Notable Monday Option Activity: TNDM, ETSY, ADVM

Notable Monday Option Activity: TNDM, ETSY, ADVM

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Tandem Diabetes Care Inc , where a total volume of 7,328 contracts has been traded thus far today, a contract volume which is representative of approximately 732,800 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 57.4% of TNDM's average daily trading volume over the past month, of 1.3 million shares.

Tandem Diabetes Care Announces Upcoming Conference Participation And Presentations

Tandem Diabetes Care Announces Upcoming Conference Participation And Presentations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will be attending the following upcoming investor conferences: Baird Global Healthcare Conference on Wednesday,...

The Charts of Tandem Diabetes Are Probably Headed Higher With This Subtle Clue

The Charts of Tandem Diabetes Are Probably Headed Higher With This Subtle Clue

The market potential for TNDM is even greater worldwide.

Tandem Diabetes Care Announces Second Quarter 2019 Financial Results And Updated 2019 Financial Guidance

Tandem Diabetes Care Announces Second Quarter 2019 Financial Results And Updated 2019 Financial Guidance

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2019 and updated its financial guidance for the year ending December 31, 2019.

Tandem Diabetes Care Announces No-Cost Software Updates For T:slim X2 Insulin Pump Customers In The United States

Tandem Diabetes Care Announces No-Cost Software Updates For T:slim X2 Insulin Pump Customers In The United States

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it is offering no-cost feature updates for t:slim X2 insulin pump customers in the United States through the end of 2020.

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Go-Go Growth: Cramer's 'Mad Money' Recap (Tuesday 7/23/19)

Jim Cramer says higher sales, higher prices, and demand from emerging markets seem to be fueling a return to the days of great senior growth stocks.

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Pfizer, eBay, Cloudera: 'Mad Money' Lightning Round

Jim Cramer weighs in on Pfizer, eBay, Cloudera, Cadence Systems, CRISPR Therapeutics, Moderna, Tandem Diabetes Care, and more.

Notable Friday Option Activity: TNDM, CRCM, GM

Notable Friday Option Activity: TNDM, CRCM, GM

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Tandem Diabetes Care Inc , where a total of 5,176 contracts have traded so far, representing approximately 517,600 underlying shares. That amounts to about 49.9% of TNDM's average daily trading volume over the past month of 1.0 million shares.

Tandem Diabetes Care To Announce Second Quarter 2019 Financial Results On August 1, 2019

Tandem Diabetes Care To Announce Second Quarter 2019 Financial Results On August 1, 2019

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2019 results after the financial markets close on Thursday, August 1, 2019.

Tandem Diabetes Care Announces Upcoming Conference Presentation

Tandem Diabetes Care Announces Upcoming Conference Presentation

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present at the BMO 2019 Prescriptions for Success Healthcare Conference...

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Tandem Diabetes Care, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Tandem Diabetes Care, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors

NEW YORK, June 19, 2019 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Tandem...

Tandem Diabetes Care Reports Positive Results From Two Studies Of The T:slim X2 Insulin Pump With Control-IQ Technology

Tandem Diabetes Care Reports Positive Results From Two Studies Of The T:slim X2 Insulin Pump With Control-IQ Technology

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced positive results from two studies of the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology.

Tandem Diabetes Care Announces Conference Call Following Data Presentations At The ADA Scientific Sessions

Tandem Diabetes Care Announces Conference Call Following Data Presentations At The ADA Scientific Sessions

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will hold a conference call on Sunday, June 9, 2019 at 8:00pm Eastern Time (5:00pm Pacific Time) following data...

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a Company update at the following upcoming investor conferences: Bank of America Merrill Lynch Healthcare...

Tandem Diabetes Care Announces First Quarter 2019 Financial Results And Updated 2019 Financial Guidance

Tandem Diabetes Care Announces First Quarter 2019 Financial Results And Updated 2019 Financial Guidance

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2019 and updated its financial guidance for the year ending December 31, 2019.

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

DexCom, HCA Healthcare, Tractor Supply: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at DexCom, HCA Healthcare, Tractor Supply, Sarepta Therapeutics, The Blackstone Group, HNI Corp. and more.

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Investing's Not a Game: Cramer's 'Mad Money' Recap (Thursday 4/25/19)

Jim Cramer says it's the start CNBC's annual Stock Draft Contest, but he cautions Mad Money viewers that although investing can be fun, it requires discipline and doing your homework.

Tandem Diabetes Care To Announce First Quarter 2019 Financial Results On April 30, 2019

Tandem Diabetes Care To Announce First Quarter 2019 Financial Results On April 30, 2019

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2019 results after the financial markets close on Tuesday, April 30, 2019.

Bankers on the Grill: Cramer's 'Mad Money' Recap (Wednesday 4/10/19)

Bankers on the Grill: Cramer's 'Mad Money' Recap (Wednesday 4/10/19)

Averages barely budge, despite grilling of banking CEOS by lawmakers. Jim Cramer talks about earnings and the great divide in Washington.

Yeti holdings, Tandem Diabetes, Electronic Arts: 'Mad Money' Lightning Round

Yeti holdings, Tandem Diabetes, Electronic Arts: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Yeti holdings, Tandem Diabetes Care, Electronic Arts, Aurora Cannabis, PacWest Bancorp and more.

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

What More Do They Want?: Cramer's 'Mad Money' Recap (Monday 3/25/19)

Apple couldn't do much to hold back the bears today, but Jim Cramer says the company's services segment is the most important thing and he's more than happy with it.

Jim Cramer: Blockbuster Ideas That I Know Would Move Apple's Needle

Jim Cramer: Blockbuster Ideas That I Know Would Move Apple's Needle

What would the people who help determine AAPL's stock price really want?

Playbook for the Fed: Cramer's 'Mad Money' Recap (Thursday 3/21/19)

Playbook for the Fed: Cramer's 'Mad Money' Recap (Thursday 3/21/19)

Jim Cramer has a playbook for finding the stocks that can make money without the economy filling the sails.

TheStreet Quant Rating: D- (Sell)